ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
Healthcare
$12.82 +0.73%
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
52W Low $16.64High $23.21
Volume 0.65M
Average 1.06M
ADRX Other Financing Activities
Financing cash flows not reported separately.
No reported Other Financing Activities figures are available to summarize.
Other Financing Activities history
Currency unavailable · from the cash flow
No Other Financing Activities data reported for this period type.
Other Financing Activities vs competitors
How ADRX compares with its peers on the latest reported figures
ADRX Competitors
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $151.51M USD | +200.4% | — | 3755.9% | |
| FY2025 | $42.57M USD | — | — | 228.7% | |
| LTM Mar 2026 | $14.23M USD | -515.6% | — | 31.4% | |
| LTM Mar 2026 | $5.95M USD | +24.7% | -14.2% | 7.5% | |
| LTM Mar 2026 | $3.07M USD | -84.7% | — | 4.3% | |
| LTM Mar 2026 | $178.7K USD | -82.2% | — | — | |
| LTM Mar 2026 | €5.85K EUR | -100.0% | +30.3% | 0.0% | |
| LTM Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — | — |
| Peer median (excluding ADRX) | — | -84.7% | +8.0% | 5.9% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Currency unavailable
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.